Evidence map›Paper›PMID 19321723›Full record

ArticleJournal of clinical microbiology2009

Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility.

Mónica Azor, Josepa Gené, Josep Cano, Palanisamy Manikandan, Narendran Venkatapathy, Josep Guarro

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. PrenylatedMolecules (Basel, Switzerland) · 2021
    Article
  2. Review
  3. Neotypification ofFungal systematics and evolution · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Outbreak ofAntimicrobial resistance and infection control · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mónica AzorUnitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/ Sant Llorenç 21, 43201 Reus, Tarragona, Spain. josepa.gene@urv.cat.
Josepa Gené
Josep Cano
Palanisamy Manikandan
Narendran Venkatapathy
Josep Guarro

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Forty-eight Fusarium isolates morphologically identified as belonging to seven species of clinical interest (i.e., Fusarium chlamydosporum, Fusarium dimerum, Fusarium incarnatum, Fusarium napiforme, Fusarium nygamai, Fusarium proliferatum, and Fusarium sacchari) were characterized molecularly by the analysis of the sequences of the TUB region of the beta-tubulin gene. F. chlamydosporum and F. dimerum were the most genetically heterogeneous species. A high degree of correlation between the morphological and molecular identification was shown among the isolates studied. A table with the key morphological features for the identification of these Fusarium species is provided. The antifungal susceptibilities of the Fusarium isolates to 11 antifungal drugs were tested; terbinafine was the most active drug against all the species tested with the exception of F. incarnatum, for which amphotericin B was the most active.

Indexed as

Amphotericin BAntifungal AgentsDNA, FungalFungal ProteinsFusariumHumansMicrobial Sensitivity TestsMolecular Sequence DataMycosesNaphthalenesPolymorphism, GeneticSequence Analysis, DNATerbinafineTubulinAmphotericin BAntifungal AgentsDNA, FungalFungal ProteinsNaphthalenesTerbinafineTubulin

Identifiers

PMID19321723
PMCPMC2681829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.